FELIX DRON: Open Payments
NPI 1518986561 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,460 in 89 payments from 12 companies in 2025. Trend: 2023 $1,891 · 2024 $1,862 · 2025 $2,460
Food & beverage: $2,323Education: $137
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 16 | $366 |
| Lundbeck LLC | 11 | $333 |
| Axsome Therapeutics, Inc. | 10 | $330 |
| Alkermes, Inc. | 12 | $329 |
| Teva Pharmaceuticals USA, Inc. | 12 | $319 |
| Otsuka America Pharmaceutical, Inc. | 10 | $265 |
| E.R. Squibb & Sons, L.L.C. | 4 | $146 |
| Almatica Pharma LLC | 6 | $146 |
| ABBVIE INC. | 5 | $128 |
| Neurocrine BioSciences, Inc. | 1 | $35 |
Products named: REXULTI, FANAPT, Auvelity, LYBALVI, ABILIFY ASIMTUFII, AUSTEDO XR, LOREEV XR, VRAYLAR.
Industry payments across NY — which companies pay providers there.
